Sleep Apnea Recruiting Phase 4 Trials for Oxymetazoline (DB00935)

Also known as: Sleep apnoeas / Sleep Apnoea / Sleep Apnea Syndrome / Apnea, Sleep / Sleep Apnea Syndromes / Sleep apnoea syndromes / Sleep apnoea syndrome / Apnea syndrome / Apnoea syndrome

IndicationStatusPhase
DBCOND0030087 (Sleep Apnea)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02630121Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep ApneaTreatment